European Biotechs Enter the IPO Big League
Genmab's NASDAQ Debut Biggest of 2019
2019 has seen European biotech companies making waves in the US IPO space. Genmab’s listing was a blockbuster, but many more companies have proven their ability to go public on the NASDAQ.
